Information and Policies for ACPA’s 79th Annual Meeting, March 30 – April 2, 2022, are listed below.
In accordance with CDC and FDA evidence and guidelines, all attendees must be fully vaccinated against COVID-19 to attend the in-person 79th Annual Meeting. Read our full policy and FAQs.
ACPA is committed to compliance with the Americans with Disabilities Act and to making ACPA’s Annual Meeting accessible to all. Attendees who need accommodations in order to participate should contact the ACPA National Office Team before the meeting and may contact Dan Derman (919-933-9044 ext. 213 or email@example.com) during the Annual Meeting for assistance. Requests made during the live meeting will be accommodated to the best of our ability.
ACPA is not responsible for any defamatory, offensive, or illegal conduct of Annual Meeting participants, and shall not be held liable for personal injury, property damage, theft or damage of any kind suffered by the participants at or in connection with ACPA’s Annual Meeting.
All refunds will be processed after the meeting. All cancellations must be received in writing (email is acceptable) and include the original purchase date.
ACPA shall not be liable for any loss, injury, or damage to person or property resulting directly or indirectly from any acts of God, acts of government or other authorities, civil disturbances, acts of terrorism, riots, thefts, or from any other similar causes.
All attendees are also required to abide by the ACPA COVID-19 safety guidelines.
- ACPA, in compliance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, has adopted the following Full Disclosure Policy: Presentations made at continuing medical educational activities sponsored or jointly sponsored by ACPA must include information regarding all commercial or industrial funding, consulting, or equity holdings by the presentations’ author(s) and/or anyone related to the author(s) that could be affected by or could have an effect on the content of the presentation. This information is requested during the abstract submission process and will be disclosed to participants through statements in printed meeting materials. The American Cleft Palate-Craniofacial Association (ACPA), in compliance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education (Released December 2020), the American Speech-Language Hearing Association’s (ASHA) Continuing Education Board’s Requirements, and the requirements of the American Nurses Credentialing Center’s (ANCC) Commission on Accreditation, has adopted the following Disclosure Policy which requires disclosure of all financial relationships with ineligible companies which have existed within the last 24 months. An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing health products used by or on patients. (For specific examples of ineligible companies, visit accme.org/standards.).
- ACPA’s Disclosure Policy also requires disclosure of all non-financial relationships that might bias an individual including any personal, professional, political, institutional, religious, personal interest, or other relationship (e.g. personal interest or cultural bias) and that could influence the information presented or be perceived as a conflict of interest by learners.
Only ACPA’s authorized vendors are permitted to video and/or audio-record scientific sessions. Recording or streaming of individual sessions, including livestreaming on any media platforms without prior authorization from ACPA is strictly prohibited. Those found violating this policy will be removed from the session immediately and any recording for commercial or personal use will be deleted.
Please contact firstname.lastname@example.org if you have any questions or need assistance.